Yong Rong (Hk) Asset Management LTD Biogen Inc. Transaction History

Yong Rong (Hk) Asset Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $3.34 Million - $4.23 Million	-12,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $3.52 Million - $4.61 Million	12,000 New	12,000 $4.24 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $721,056 - $859,348	-2,800 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $728,364 - $1.03 Million	2,800 New	2,800 $767,000

1,022

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Yong Rong (Hk) Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Yong Rong (Hk) Asset Management LTD with notifications on news.